REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/18/2025
Back to search
Official data from USPTO
OXC-BETA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
02/18/2025
Trademark type
Word
Nice classes
5
Filing date
07/11/2016
Registration date
02/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2020
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Ottawa, Ontario, CA
Examiner
RINKER, ANTHONY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Avivagen Inc.
Representatives
Jeffrey J. Ellison Clark+Elbing LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Adjuvants for use with vaccines; Animal feed additives and supplements; Anti-infective products for veterinary use; Anti-inflammatories; Dietarynutritionals and food supplements; Nutritional supplements for general health and well-being; Dietary food supplements for general health and well-being; Medicated dermatological preparations and substances; Medicated skin care preparations; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplements for supporting immune function; Nutritional supplements for catsdogshorseslivestock; Pharmaceutical preparations for treatment of infectious diseasesrespiratory infectionseye infections; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of viralrespiratorygastrointestinaldermatologicalimmune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of bacterial infections; Pharmaceutical preparations for the treatment of bacterial skin infectionsfungal skin infectionsviral skin infections and parasitic skin infections; Pharmaceutical preparations for the prevention and treatment of disorders of the immune systemPharmaceutical preparations for treatment of respiratory diseasesdisorders and infections; Pharmaceutical preparations for the treatment of inflammatory disorders and diseasesinflammatory bowel diseasesinflammatory connective tissue diseases; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Veterinary preparations for treatment of intestinal bacteria; Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; Veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; Veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; Veterinary pharmaceutical preparations for treatment of infectious diseaserespiratory infectionseye infectionstopical infections; Veterinary pharmaceutical preparations for the treatment of infectious diseasesswine dysenterybacterial enteritisbluecombpneumonia; Veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; Veterinary pharmaceutical preparations for treatment of intestinal bacteria
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2019
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/28/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/22/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/11/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/11/2019
CNSI
SUSPENSION INQUIRY WRITTEN
10/11/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/23/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/18/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/18/2019
CNSL
SUSPENSION LETTER WRITTEN
03/18/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/26/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/16/2018
GNSL
LETTER OF SUSPENSION E-MAILED
08/16/2018
CNSL
SUSPENSION LETTER WRITTEN
08/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2018
ALIE
ASSIGNED TO LIE
07/31/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/27/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/19/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/19/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/23/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/23/2018
CNSI
SUSPENSION INQUIRY WRITTEN
05/23/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/02/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/18/2017
GNSL
LETTER OF SUSPENSION E-MAILED
10/18/2017
CNSL
SUSPENSION LETTER WRITTEN
10/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/26/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/22/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/22/2017
CNSI
SUSPENSION INQUIRY WRITTEN
05/22/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/09/2017
ALIE
ASSIGNED TO LIE
05/05/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/27/2016
GNSL
LETTER OF SUSPENSION E-MAILED
10/27/2016
CNSL
SUSPENSION LETTER WRITTEN
10/27/2016
DOCK
ASSIGNED TO EXAMINER
10/19/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2016
NWAP
NEW APPLICATION ENTERED
07/14/2016
Continuous trademark protection
Get notified about every new filing that threatens OXC-BETA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.